Company / SG&A per Share
Dyne Therapeutics, Inc. SG&A per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.61
FY2024
5-year range
$0.51 / $0.93
FY2020-FY2024
Trend
+19.5%
vs FY2023
Sector context
#155 of 208
Health Care
What the data says
Dyne Therapeutics, Inc.'s sg&a per share of $0.61 is lower than 75% of companies in the Health Care sector (FY2024). Increased from $0.51 to $0.61 over the past 2 years.
Based on SEC 10-K filings.
0.61 in FY2024 with a 5-year CAGR of -11.7%.
Increased from $0.51 to $0.61 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +2.7%
- 5-Year CAGR
- -11.7%
- 10-Year CAGR
- -
Sector benchmark
Top 25% in Health CareTop 25% of 208This company $0.61 Sector average $29.78
▼
-97.9% below sector average
Key checks
Key Insights
- In FY2024, sg&a per share increased 19.5% year-over-year.
- Ranks #155 out of 208 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2019.
- Lowest sg&a per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 3.40 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.61 | +19.5% |
| FY2023 | $0.51 | +0.8% |
| FY2022 | $0.51 | -10.2% |
| FY2021 | $0.56 | -39.6% |
| FY2020 | $0.93 | -18.1% |
| FY2019 | $1.14 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026